Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie Raises Outlook on Strong Performance Amid Shire Offer
Bloomberg
Mon, 06/23/14 - 09:41 am
Tags:
AbbVie, Shire, M&A, guidance
AbbVie’s Gonzalez Seeks Quick Diversity With Shire Offer
Bloomberg
Mon, 06/23/14 - 09:39 am
Tags:
AbbVie, Richard Gonzalez, Shire, M&A, diversification
Shire to set out AstraZeneca-style defense against AbbVie
Yahoo/Reuters
Mon, 06/23/14 - 09:37 am
Tags:
Shire, Pfizer, M&A, AstraZeneca, AbbVie
Shire Rejecting AbbVie’s Bid Puts It in Play: Real M&A
Bloomberg
Sat, 06/21/14 - 11:41 am
Tags:
Shire, AbbVie, M&A
AbbVie’s Shire Push Won’t Face Pfizer Hurdles in Takeover
Bloomberg
Sat, 06/21/14 - 11:39 am
Tags:
AbbVie, Shire, M&A
AbbVie’s Shire Push Won’t Face Pfizer Hurdles in Takeover
Bloomberg
Fri, 06/20/14 - 06:19 pm
Tags:
Shire, AbbVie, M&A, Pfizer
AbbVie: Is Shire Just Playing Hard to Get?
Barron's
Fri, 06/20/14 - 06:18 pm
Tags:
AbbVie, Shire, M&A
AbbVie fails to woo Shire, but investors think someone can do it
Marketwatch
Fri, 06/20/14 - 11:22 am
Tags:
AbbVie, Shire, M&A
FDA asks for wider warning on testosterone products
Yahoo/Reuters
Fri, 06/20/14 - 09:41 am
Tags:
FDA, testosterone, AbbVie, Endo Health Solutions
AbbVie - Attempt To Acquire Shire Is Driven By Opportunistic Tax Synergies
Seeking Alpha
Fri, 06/20/14 - 09:40 am
Tags:
AbbVie, Shire, taxes, M&A
AbbVie Offered $46.5 Billion for Shire as Bid Rejected
Bloomberg
Fri, 06/20/14 - 09:36 am
Tags:
Shire, AbbVie, M&A
Expecting hostile suitors, Shire brings in reinforcements
Fierce Pharma
Wed, 06/18/14 - 05:31 am
Tags:
Shire, M&A, Bristol-Myers Squibb, Amgen, AbbVie, Gilead Sciences, Biogen Idec
Is This Gilead's Worst Nightmare?
Motley Fool
Tue, 06/17/14 - 07:00 pm
Tags:
Gilead Sciences, Sovaldi, hepatitis C, Enanta Pharmaceuticals, AbbVie
Biogen, AbbVie drug slows MS episodes, safety issues recur
Yahoo/Reuters
Mon, 06/16/14 - 08:35 pm
Tags:
AbbVie, Biogen Idec, MS, multiple sclerosis, daclizumab
Biogen, AbbVie drug slows MS episodes, safety issues recur
Yahoo/Reuters
Mon, 06/16/14 - 10:17 am
Tags:
Biogen, AbbVie, daclizumab, MS, multiple sclerosis
Enanta notes AbbVie granted FDA priority review for Hep C combo regimen
Yahoo/Fly on the Wall
Fri, 06/13/14 - 06:44 pm
Tags:
AbbVie, Enanta Pharmaceuticals, FDA, hepatitis C, ABT-450
HCV players moving after Merck buys Idenix
The Fly on the Wall
Mon, 06/9/14 - 12:01 pm
Tags:
Merck, Gilead Sciences, Idenix, M&A, Achillion, JNJ, AbbVie
Abbott, AbbVie get to defend testosterone lawsuits on their own turf
Fierce Pharma
Mon, 06/9/14 - 11:28 am
Tags:
Abbott, AbbVie, testosterone, Androgel
FirstWord List: Top 15 pharma and lead product dependency
First Word Pharma
Mon, 06/9/14 - 10:35 am
Tags:
Teva, AbbVie, Boehringer Ingelheim, GSK, Sanofi, Amgen, Eli Lilly, JNJ, AstraZeneca, Roche, Novartis, Merck, Pfizer, Takeda, Bristol-Myers Squibb
Achillion Pharma Might be Next Hep C Takeout Target
TheStreet.com
Mon, 06/9/14 - 09:40 am
Tags:
Achillion, hepatitis C, M&A, JNJ, AbbVie, Merck, Idenix

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.